-
Uncategorized2 weeks ago
FDA Blueprint Aims To Cut Regulatory Risk for Alternatives to Animal Testing
Draft guidance, issued by the FDA last week, could remove ambiguity and uncertainty that may have so far limited uptake of new approach methodologies, experts told...
-
Uncategorized2 weeks ago
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
Like its pharma peers, Novartis is pouring money into Chinese operations, including expansions and upgrades at an existing manufacturing facility.
-
Uncategorized2 weeks ago
Aardvark Pauses 2 Obesity Trials, Reveals New Details on Cardiac Concerns
Aardvark Therapeutics’ obesity asset is based on its lead molecule, which in February was linked to reversible heart safety signals in a healthy volunteer study.
-
Uncategorized2 weeks agoResearch uncovers how prostate cancer cells resist treatment
Researchers at Texas A&M Health have identified a molecular mechanism that increases cholesterol levels inside prostate cancer cells—an important process that may help explain how some...
-
Uncategorized2 weeks ago
Gilead Chief Gets 20% Pay Bump, Still Falls Short of $30M Club
Gilead’s median employee compensation in 2025 was $238,979. Daniel O’Day’s compensation package is 119 times larger.
-
Uncategorized2 weeks ago
Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos
Following last month’s $7.8 billion purchase of CAR T biotech Arcellx, Gilead’s dealmaking train chugs along with yet another acquisition—this time securing Ouro Medicines’ pipeline of...
-
Uncategorized2 weeks agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis has agreed a deal with Synnovation Therapeutics to acquire Pikavation Therapeutics and its portfolio of PI3Kα inhibitor programmes, including SNV4818. Pikavation is a wholly-owned subsidiary...
-
Uncategorized2 weeks agoLaigo Bio raises $17m to advance oncology pipeline
Biotech company Laigo Bio has completed the second close of its seed financing round with an additional $5.5 million bringing the total investment to $17 million. Laigo will...
-
Uncategorized2 weeks agoNHS health data should be used for clinical trial recruitment, says ABPI
The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit...
-
Uncategorized2 weeks agoLast chance to register: Understand LC-MS quantification strategies for proteins
A new event, hosted by DDW and supported by Evotec, will explore cutting-edge LC-MS-based bioanalytical approaches tailored for the quantitative analysis of therapeutic proteins, such as...
BioNTech to shutter Singapore HQ after ‘comprehensive review’
STAT+: Merck’s experimental HIV prevention pill could be made for less than $5 a year, researchers say
